The disclosure relates to bicyclic amides such as 6-(6-Hydroxymethyl-pyrimidin-4-yloxy)-naphthalene-1-carboxylic acid (3-trifluoromethylphenyl)-amide, or a tautomer thereof, or a salt thereof, which are suitable in the treatment of a protei…
The disclosure relates to bicyclic amides such as 6-(6-Hydroxymethyl-pyrimidin-4-yloxy)-naphthalene-1-carboxylic acid (3-trifluoromethylphenyl)-amide, or a tautomer thereof, or a salt thereof, which are suitable in the treatment of a protei…
The disclosure relates to bicyclic amides such as 6-(6-Hydroxymethyl-pyrimidin-4-yloxy)-naphthalene-1-carboxylic acid (3-trifluoromethylphenyl)-amide, or a tautomer thereof, or a salt thereof, which are suitable in the treatment of a protei…
The disclosure relates to bicyclic amides such as 6-(6-Hydroxymethyl-pyrimidin-4-yloxy)-naphthalene-1-carboxylic acid (3-trifluoromethylphenyl)-amide, or a tautomer thereof, or a salt thereof, which are suitable in the treatment of a protei…
The disclosure relates to bicyclic amides such as 6-(6-Hydroxymethyl-pyrimidin-4-yloxy)-naphthalene-1-carboxylic acid (3-trifluoromethylphenyl)-amide, or a tautomer thereof, or a salt thereof, which are suitable in the treatment of a protei…
The disclosure relates to bicyclic amides such as 6-(6-Hydroxymethyl-pyrimidin-4-yloxy)-naphthalene-1-carboxylic acid (3-trifluoromethylphenyl)-amide, or a tautomer thereof, or a salt thereof, which are suitable in the treatment of a protei…
The disclosure relates to bicyclic amides such as 6-(6-Hydroxymethyl-pyrimidin-4-yloxy)-naphthalene-1-carboxylic acid (3-trifluoromethylphenyl)-amide, or a tautomer thereof, or a salt thereof, which are suitable in the treatment of a protei…
The disclosure relates to bicyclic amides such as 6-(6-Hydroxymethyl-pyrimidin-4-yloxy)-naphthalene-1-carboxylic acid (3-trifluoromethylphenyl)-amide, or a tautomer thereof, or a salt thereof, which are suitable in the treatment of a protei…
The disclosure relates to bicyclic amides such as 6-(6-Hydroxymethyl-pyrimidin-4-yloxy)-naphthalene-1-carboxylic acid (3-trifluoromethylphenyl)-amide, or a tautomer thereof, or a salt thereof, which are suitable in the treatment of a protei…
The disclosure relates to bicyclic amides such as 6-(6-Hydroxymethyl-pyrimidin-4-yloxy)-naphthalene-1-carboxylic acid (3-trifluoromethylphenyl)-amide, or a tautomer thereof, or a salt thereof, which are suitable in the treatment of a protei…
The disclosure relates to bicyclic amides such as 6-(6-Hydroxymethyl-pyrimidin-4-yloxy)-naphthalene-1-carboxylic acid (3-trifluoromethylphenyl)-amide, or a tautomer thereof, or a salt thereof, which are suitable in the treatment of a protei…
The disclosure relates to bicyclic amides such as 6-(6-Hydroxymethyl-pyrimidin-4-yloxy)-naphthalene-1-carboxylic acid (3-trifluoromethylphenyl)-amide, or a tautomer thereof, or a salt thereof, which are suitable in the treatment of a protei…
The disclosure relates to bicyclic amides such as 6-(6-Hydroxymethyl-pyrimidin-4-yloxy)-naphthalene-1-carboxylic acid (3-trifluoromethylphenyl)-amide, or a tautomer thereof, or a salt thereof, which are suitable in the treatment of a protei…
The disclosure relates to bicyclic amides such as 6-(6-Hydroxymethyl-pyrimidin-4-yloxy)-naphthalene-1-carboxylic acid (3-trifluoromethylphenyl)-amide, or a tautomer thereof, or a salt thereof, which are suitable in the treatment of a protei…
The disclosure relates to bicyclic amides such as 6-(6-Hydroxymethyl-pyrimidin-4-yloxy)-naphthalene-1-carboxylic acid (3-trifluoromethylphenyl)-amide, or a tautomer thereof, or a salt thereof, which are suitable in the treatment of a protei…
The disclosure relates to bicyclic amides such as 6-(6-Hydroxymethyl-pyrimidin-4-yloxy)-naphthalene-1-carboxylic acid (3-trifluoromethylphenyl)-amide, or a tautomer thereof, or a salt thereof, which are suitable in the treatment of a protei…
The disclosure relates to bicyclic amides such as 6-(6-Hydroxymethyl-pyrimidin-4-yloxy)-naphthalene-1-carboxylic acid (3-trifluoromethylphenyl)-amide, or a tautomer thereof, or a salt thereof, which are suitable in the treatment of a protei…
The disclosure relates to bicyclic amides such as 6-(6-Hydroxymethyl-pyrimidin-4-yloxy)-naphthalene-1-carboxylic acid (3-trifluoromethylphenyl)-amide, or a tautomer thereof, or a salt thereof, which are suitable in the treatment of a protei…
The disclosure relates to bicyclic amides such as 6-(6-Hydroxymethyl-pyrimidin-4-yloxy)-naphthalene-1-carboxylic acid (3-trifluoromethylphenyl)-amide, or a tautomer thereof, or a salt thereof, which are suitable in the treatment of a protei…
The disclosure relates to bicyclic amides such as 6-(6-Hydroxymethyl-pyrimidin-4-yloxy)-naphthalene-1-carboxylic acid (3-trifluoromethylphenyl)-amide, or a tautomer thereof, or a salt thereof, which are suitable in the treatment of a protei…
The disclosure relates to bicyclic amides such as 6-(6-Hydroxymethyl-pyrimidin-4-yloxy)-naphthalene-1-carboxylic acid (3-trifluoromethylphenyl)-amide, or a tautomer thereof, or a salt thereof, which are suitable in the treatment of a protei…
The disclosure relates to bicyclic amides such as 6-(6-Hydroxymethyl-pyrimidin-4-yloxy)-naphthalene-1-carboxylic acid (3-trifluoromethylphenyl)-amide, or a tautomer thereof, or a salt thereof, which are suitable in the treatment of a protei…
The disclosure relates to bicyclic amides such as 6-(6-Hydroxymethyl-pyrimidin-4-yloxy)-naphthalene-1-carboxylic acid (3-trifluoromethylphenyl)-amide, or a tautomer thereof, or a salt thereof, which are suitable in the treatment of a protei…
The disclosure relates to bicyclic amides such as 6-(6-Hydroxymethyl-pyrimidin-4-yloxy)-naphthalene-1-carboxylic acid (3-trifluoromethylphenyl)-amide, or a tautomer thereof, or a salt thereof, which are suitable in the treatment of a protei…
The disclosure relates to bicyclic amides such as 6-(6-Hydroxymethyl-pyrimidin-4-yloxy)-naphthalene-1-carboxylic acid (3-trifluoromethylphenyl)-amide, or a tautomer thereof, or a salt thereof, which are suitable in the treatment of a protei…